The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II randomized placebo-controlled neoadjuvant trial of nintedanib or placebo with gemcitabine and cisplatin in locally advanced muscle invasive bladder cancer (NEO-BLADE).
 
Syed A. Hussain
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; GlaxoSmithKline; Janssen Oncology; Merck; Pfizer; Pierre Fabre; Roche; Sotio
Research Funding - Boehringer Ingelheim; Janssen-Cilag; Pierre Fabre
Travel, Accommodations, Expenses - Bayer; Boehringer Ingelheim; Janssen-Cilag; MSD Oncology; Pfizer; Pierre Fabre; Roche
 
Jason Francis Lester
No Relationships to Disclose
 
Richard Jackson
No Relationships to Disclose
 
Matthew Gornall
No Relationships to Disclose
 
Anthony Elliott
No Relationships to Disclose
 
Simon J. Crabb
Honoraria - Astellas Pharma; Bayer; Janssen-Cilag; MSD; Roche
Consulting or Advisory Role - AstraZeneca; Bayer; BeiGene; Clovis Oncology; Janssen-Cilag; MSD; Roche
Research Funding - Astex Pharmaceuticals; AstraZeneca; Clovis Oncology; Plexxikon
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Janssen-Cilag; Roche
 
Robert A. Huddart
Leadership - Cancer clinic london Limited liability partnership
Honoraria - Janssen Oncology
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen Oncology; Merck Sharp & Dohme; Nektar; Roche
Speakers' Bureau - MSD; Roche
Research Funding - Bristol-Myers Squibb (Inst); Janssen (Inst); Merck Sharp & Dohme (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - Royalties for dug discovery from Janssen (Inst)
Travel, Accommodations, Expenses - Janssen Oncology; MSD Oncology; Roche/Genentech
 
Naveen Vasudev
No Relationships to Disclose
 
Alison Jane Birtle
Honoraria - Janssen-Cilag
Consulting or Advisory Role - Astellas Medivation; AstraZeneca; Bayer Schering Pharma; Janssen Oncology; Roche; Sanofi
 
Jane Worlding
No Relationships to Disclose
 
Nicholas D. James
Honoraria - Astellas Pharma; Bayer; Janssen; Oncogenex; Pierre Fabre; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Clovis Oncology; EUSA pharma; Janssen; pfizer; Sanofi
Speakers' Bureau - Astellas Pharma; Ferring; Janssen Oncology; Pierre Fabre; Sanofi
Research Funding - Astellas Pharma (Inst); Janssen (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Janssen; Sanofi
 
Omi Parikh
No Relationships to Disclose
 
Maria Vilarino varela
No Relationships to Disclose
 
Roberto Alonzi
No Relationships to Disclose
 
Mark David Linch
No Relationships to Disclose
 
Thomas Powles
Honoraria - AstraZeneca; Bristol-Myers Squibb; Ferring; Gerson Lehrman Group; Janssen Research & Development; MERCK; Novartis; Pfizer; Roche/Genentech; Seattle Genetics/Astellas
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Incyte; Ipsen; Merck; Novartis; Novartis; Pfizer; Seagen
Research Funding - AstraZeneca/MedImmune; Roche/Genentech
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Ferring; MSD; Novartis/Ipsen; Pfizer; Research to Practice; Roche/Genentech
 
Robert J. Jones
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; EUSA Pharma; Ipsen; Janssen; MSD Oncology; Novartis; Pfizer; Pharmacyclics; Roche/Genentech; Sanofi; Seagen
Consulting or Advisory Role - Clovis Oncology
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Exelixis (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Ipsen; Janssen; MSD